The Global Renin-Inhibitors Market was valued at 70.79 Million USD in 2020 and will grow with a CAGR of 6% during the forecast period 2022 to 2028. Renin inhibitors are medicines that reduce the formation of geotensin II, which lowers blood pressure by inhibiting the activity of renin, which is responsible for the hydrolysis of geotensinogen to […]
